Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Weatherall

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
BMC Medicine|November 8, 2016
It's a long shot, but it just might work! Perspectives on the future of medicinePaul Wicks, Matthew Hotopf, Vaibhav A Narayan, et al.
Clinical Pharmacology and Therapeutics|December 21, 2023
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and OpportunitiesAlicia Curth, Richard W Peck, Eoin McKinney, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 2 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
Cancer Discovery|April 18, 2026
Enabling AI to Drive Innovation and Precision across Oncology R&DRichard J A Goodwin, Simon T Barry, James Weatherall, et al.
Health and Quality of Life Outcomes|May 4, 2018
When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigationJames Weatherall, William H Polonsky, Sally Lanar, et al.
Drug Discovery Today|November 3, 2025
Implementation of a data science and artificial intelligence strategy across pharmaceutical R&D: challenges and solutionsVincenzo Garzya, Gabriella Rustici, Tom Diethe, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Machine learning for clinical trials in the era of COVID-19William R Zame, Ioana Bica, Cong Shen, et al.
Nature Reviews. Drug Discovery|July 15, 2024
Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtableNajat S Khan, Thomas Senderovitz, James Weatherall, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
BMC Medicine|November 8, 2016
It's a long shot, but it just might work! Perspectives on the future of medicinePaul Wicks, Matthew Hotopf, Vaibhav A Narayan, et al.
Clinical Pharmacology and Therapeutics|December 21, 2023
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and OpportunitiesAlicia Curth, Richard W Peck, Eoin McKinney, et al.
Current Medical Research and Opinion|October 12, 2017
The burden of severe hypoglycemia in type 2 diabetesJieruo Liu, Rosa Wang, Michael L Ganz, et al.
Cancer Discovery|April 18, 2026
Enabling AI to Drive Innovation and Precision across Oncology R&DRichard J A Goodwin, Simon T Barry, James Weatherall, et al.
Health and Quality of Life Outcomes|May 4, 2018
When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigationJames Weatherall, William H Polonsky, Sally Lanar, et al.
Drug Discovery Today|November 3, 2025
Implementation of a data science and artificial intelligence strategy across pharmaceutical R&D: challenges and solutionsVincenzo Garzya, Gabriella Rustici, Tom Diethe, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Machine learning for clinical trials in the era of COVID-19William R Zame, Ioana Bica, Cong Shen, et al.
Nature Reviews. Drug Discovery|July 15, 2024
Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtableNajat S Khan, Thomas Senderovitz, James Weatherall, et al.
Pageof 3